Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandostatin stungulyf, lausn 100 míkróg/ml
novartis healthcare a/s - octreotidum inn - stungulyf, lausn - 100 míkróg/ml
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandostatin stungulyf, lausn 50 míkróg/ml
novartis healthcare a/s - octreotidum inn - stungulyf, lausn - 50 míkróg/ml
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandostatin lar stungulyfsstofn og leysir, dreifa 10 mg
novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 10 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandostatin lar stungulyfsstofn og leysir, dreifa 20 mg
novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 20 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
sandostatin lar stungulyfsstofn og leysir, dreifa 30 mg
novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 30 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
fludara filmuhúðuð tafla 10 mg
genzyme europe b.v. - fludarabinum fosfat - filmuhúðuð tafla - 10 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
fludarabin actavis stungulyfs-/innrennslisþykkni, lausn 25 mg/ml
actavis group ptc ehf. - fludarabinum fosfat - stungulyfs-/innrennslisþykkni, lausn - 25 mg/ml
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
leukeran filmuhúðuð tafla 2 mg
aspen pharma trading limited - chlorambucilum inn - filmuhúðuð tafla - 2 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
histodine stungulyf, lausn 10 mg/ml
le vet beheer b.v. - chlorphenamine maleate - stungulyf, lausn - 10 mg/ml
Ευρωπαϊκή Ένωση -
Ισλανδικά -
EMA (European Medicines Agency)
spectrila
medac gesellschaft fuer klinische spezialpraeparate mbh - asparaginasi - forvarnarfrumuæxli-eitilfrumuhvítblæði - Æxlishemjandi lyf - spectrila er ætlað sem hluti af æxlishemjandi samsettri meðferð til meðhöndlunar á bráðum eitilfrumuhvítblæði (all) hjá börnum frá fæðingu til 18 ára og fullorðna.